Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury
Open Access
- 24 October 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Intensive Care Medicine
- Vol. 36 (1), 157-163
- https://doi.org/10.1007/s00134-009-1690-2
Abstract
Deposition of fibrin in the alveolar space is a hallmark of acute lung injury (ALI). Plasminogen activator inhibitor-1 (PAI-1) is an antifibrinolytic agent that is activated during inflammation. Increased plasma and pulmonary edema fluid levels of PAI-1 are associated with increased mortality in adults with ALI. This relationship has not been examined in children. The objective of this study was to test whether increased plasma PAI-1 levels are associated with worse clinical outcomes in pediatric patients with ALI. We measured plasma PAI-1 levels on the first day of ALI among 94 pediatric patients enrolled in two separate prospective, multicenter investigations and followed them for clinical outcomes. All patients met American European Consensus Conference criteria for ALI. A total of 94 patients were included. The median age was 3.2 years (range 16 days–18 years), the PaO2/FiO2 was 141 ± 72 (mean ± SD), and overall mortality was 14/94 (15%). PAI-1 levels were significantly higher in nonsurvivors compared to survivors (P < 0.01). The adjusted odds of mortality doubled for every log increase in the level of plasma PAI-1 after adjustment for age and severity of illness. Higher PAI-1 levels are associated with increased mortality and fewer ventilator-free days among pediatric patients with ALI. These findings suggest that impaired fibrinolysis may play a role in the pathogenesis of ALI in pediatric patients and suggest that PAI-1 may serve as a useful biomarker of prognosis in patients with ALI.Keywords
This publication has 31 references indexed in Scilit:
- Management of acute lung injury and acute respiratory distress syndrome in children: A different perspectiveCritical Care Medicine, 2009
- Incidence and Outcomes of Pediatric Acute Lung InjuryPediatrics, 2009
- Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome*Critical Care Medicine, 2007
- From evidence to clinical practice: Effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest*Critical Care Medicine, 2006
- Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumoniaThorax, 2004
- Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular riskThrombosis and Haemostasis, 2004
- The Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes.JCI Insight, 1996
- Depressed Bronchoalveolar Urokinase Activity in Patients with Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1990
- Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.JCI Insight, 1989